Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propion ic acid amides and related compounds

Details for Australian Patent Application No. 2008222890 (hide)

Owner Allergan, Inc.

Inventors Luhrs, Lauren M.; Schweighoffer, Fabien J.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2008222890

PCT Pub. Number WO2008/109610

Priority 60/893,196 06.03.07 US

Filing date 4 March 2008

Wipo publication date 12 September 2008

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/109610 Priority application(s): WO2008/109610

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008222904-Light filters comprising a naturally occurring chromophore and derivatives thereof

2008222865-Bacterial extract for respiratory disorders and proces for its preparation